##
|Trustees and Advisors|||
|---|---|---|
|Introduction
from the|Chief Executive Officer and Chair of||
|the Board ofTrustees|||
|Strategic Report|||
|Trustees' Report||12|
|Independent
Auditors'|Report|38|
|Statement of Financial|Activities||
|Balance Sheet||46|
|Statement ofCash Flows||48|
|Notes to the Financial|Statements|49|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Hospita
gunrises &%grteedt .||.Oesf~
Freeigesesves|||
|---|---|---|---|---|
|||ifgfgh|||
|Fixed Asset Fund|||||
|{represented
by
assets)|2,430|||2,430|
|Organisational
support||2,200||2,200|
|Become generation
fund||250||250|
|Service development
fund||600||600|
|Bililding and
maintenance||500||500|
|Information
Technology||150||150|
|General reserves|||3,117|3,357|
|Total|2,430|3,700|3,117|9,247|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Our clinical learn,|&ornp. ise|I i&fconsultants|in|palliatwc
medicine, donors, spcu&list|palliatwc
medicine, donors, spcu&list|nur
es, !herap&sts, counrillors,|nur
es, !herap&sts, counrillors,||
|---|---|---|---|---|---|---|---|---|
|healthcare a.sist &nts a&nd sorel worke. s, prov||||d& s highly
skilled and complex advice||and support|||
|Service|||Description|||How we helped|||
||||~|A 10bedded
unit||~|121 panents
cared for||
|||||||~|305 physiotherapy
sessions||
||||~|Access) to therapies,||~|100 patients supported
with||
|Inpatient
Unit||||physiotherapy,
councillors
suoal workeu|and||483 interaction)
with our
social worker||
||||~|A team dedi&aterl to providing|||||
|||||persunalised
can|||||
|l.ymphoedema
support
(this service closed in October|||13edi&ated lyrnplioedema
staff|||531 sessic&ns with 222 patient~|||
|2021).|||||||||
||||Service provided
in our counselkng|||~|&45 patienrs and family||
||||suite and by telephone
by our||||members
supported||
||||c ounselling
team||||through.||
|||||||~|294 pre and post||
||||||||bereavement
counselling||
|Counselling
services|||||||ses io s||
|||||||~|110other sessions||
|||||||~|324 ad
ho& u&nti« ts mth||
||||||||patients,
theii
family
pa&le&it'||
||||||||members
and other||
||||||||healthcare
professionals||
||||~|ielephon&'
)upper& se siuns|||||
|Therapies and
services|Wellbeing||~
~|&. C&I'I . upi&&i i &rid w&'llbc ing
)e)sin&is
I nmplernentnry
tlier,&pie'
hoint:c and cllnii al||~
~|32&&
I&id
&,«1&&ly
rt &'l&&bi&I's suf)rx&&ted wiili
440 con pk
n& ri&,i.y&neialiy
)&e '. ioi&||
|||||u&nm &tli& r &py, In&li &n head
rn,&))age, rei,&xation, refit xology
and arnatsu||~
~|3&g2 attenrlan«
~ n group
ei,)ion)
/0&I ad-ho& support contacts||
|||||||~|4
Iia t of&he MI&I me&ting.|in|
||||||||the ho&pi&.&l||
|ln the community|||Oui rnnsultants
and doctoi
)uppoit patient
and other liealth
c,ire professionals
in the
coinmunity|||~
~|Providing sneo,i&isr poilu&tr&e
«iie in thr hnrniial
T&lepnone
uppuit
to
health& are profe))ioiials
in the
comrnu
ity||
|||||||~|Ielephonc
ar:d fare to supper'||
||||||||to pauents||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
Income Generation
£6.2 million
total hospice
income in the
financial year
2021/2022
Hospice
weekly lottery
raised
£288,000
29
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Note|Unrestricted
funds
6|Restricted
funds
6|Total 2022
8|
|---|---|---|---|---|---|
|Donations
and|legacies||5,043,983|466,076|5,510,059|
|Other trading|activities||665,271||665,271|
|Investment
income|||18,200||18,200|
|Total income|||5,727,454|466,076|6,193,530|
|Raising funds|||(798,864)||(798,864)|
|Chantable
activities|||(2,395,060)|(226,041)|(2,621 0)01)|
|Total expenditure|||(3,193,924)|(226,041 )|(3,41 9,965)|
|Net income|||2,533,530|240,035|2,773,565|
|Net movement|in funds||2,533,530|240,035|2,773,565|
|Total brought|forward||6',713,456||6,713,456|
|Total funds carried forward||2'I|9,246,986|240,035|9,487,021|
|||Note|unrestricted
funds|Restricted
funds|Total 2021
E|
|---|---|---|---|---|---|
||||E|E||
|Donations
and|legacies||2,408,312|690,996|3,099,308|
|Other trading|activities||500,406||500,406|
|Investment
income|||99,754||99,754|
|Total income|||3,008,472|690,996|3,699,468|
|Raising funds|||(1,060,824)||(1,060,824)|
|Charitable
activities|||(1,873,814)|(690,996)|(2,564,810)|
|Total expenditure|||(2,934,638)|(690,996)|(3,625,634)|
|Net income|||73,834||73,834|
|Net movement|in funds||73,834||73,834|
|Total brought|forward||6,639,622||6,639,622|
|Total funds carried forward||21|6,713,456||6,713,456|
|||Note|2022
6|2021|
|---|---|---|---|---|
|Tangible assets|||2,429,868|2,512,493|
|Investments|||879,541|868,943|
||||3,309,409|3,381,436|
|Stocks|||||
|Debtors||17|1,476,850|426,962|
|Cash at bank|and in hand||5,500,329|4,185,337|
||||6,977,179|4,612,648|
|Restricted funds|||240,035||
|Unrestricted|funds||9,246,986|6,713,456|
|Total funds||21|9,487,021|6,713,456|
##
##
|arch 2|022|||||||
|---|---|---|---|---|---|---|---|
||||||Note|2022
6|2021
6|
|Net income||||||2,773,565|73,834|
|Depreciation||||||91NI83|111,022|
|Investment
income||||||(7,602)|(99,754)|
|Revaluation
ofinvestments||||||(10,598)|(81,522)|
|||||||2,849,748|3,580|
|Decrease
in stocks|||||16|349|4,651|
|(Increase)/decrease|in debtors||||17|(1,049,888)|16,098|
|Increase/(decrease)|in creditors|||||78,323|(14,222)|
|(Decrease)/increase|in deferred|||income|18|(559,384)|555,948|
|Net cash tlows from|operating||activities|||1,3'I 9,148|566,055|
|Interest receivable and similar|||income||5|7,602|99,754|
|Purchase oftangible|fixed assets|||||(8,558)||
|Sale oftangible fixed|assets|||||(3,200)|32,182|
|Net cash flows from|investing|activities||||(4,156)|131,936|
|Net increase
in cash|and cash|equivalents||||1,314,992|697,991|
|Cash and cash equivalents
at||1|Apnl|||4,185,337|3,487,346|
|Cash and cash equivalents
at||31||March||5,500,329|4,185,337|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Asset class|Depreciation
method and
rate|
|---|---|
|Equipment
fixtures and fittings|25%0 reducing
balance|
|Motor vehicles|25'ro reducing
balance|
|Buildings|over 50years|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Unrestricted
funds: General
E|Restricted funds
E|Total 2022
E|Total2021
E|
|---|---|---|---|---|---|
|Donations from companies,
trusts and similar proceeds|||||30,000|
|Donations from individuals||425,209||425,209|455,960|
|Legaoes||2,715,558||2,715,558|14,965|
|Donations from community|groups|205,403||205,403|168,752|
|Gift aid reclaimed||54,182||54,182|29|
|Government
grants||1,608,181|466,076|2,074,257|2,327,965|
|Grants from companies||35,450||35,450|101,637|
|||5,043,983|466,076|5,510,059|3,099,308|
##
##
|||||Unrestricted
General
E|funds:|Total 2022
E|Total 2021
E|
|---|---|---|---|---|---|---|---|
|Trading income||||||||
|Shop income
and services|from sale of|donated|goods|369,130||369,130|220,539
220,539|
|Other trading|income|||7,509||7,509|3,826|
|Lotteries and|compeooons|income||288,632||288,632|276,041|
|||||665,271||665,271|500,406|
||||Unrestricted
General|funds:|Total 2022|Total2021|
|---|---|---|---|---|---|---|
|||||||E|
|Interest receivable on bank deposits|||7,602||7,509|18,232|
|Movement|in investment|funds|10,598||10,598|81,522|
||||18,200||18,200|99,754|
##
|||||||Direct Costs
E||Allocated
Costs
E|Support|Total2022
E|
|---|---|---|---|---|---|---|---|---|---|---|
|Costs ofgenerating||||donations|and legaoes|351,342||154,047||505,389|
|Costs oftrading|||activioes|||201,047||92,428||293,475|
|||||||552,389||246,475||798,864|
|-Expenditure||||on charitable
activities|||||||
||||||Activity|directly|Activity|support|||
||||||undertaken||costs||Total 2022|Total 2021|
||||||E||E||||
|Inpatient|Care 8||core activities||1,626,731||688,074||2,314,805|2,179,174|
|Family|||||101,093||41,079||142,172|'I30,976|
|Day therapy||unit|||25,324||10,270||35,594|132,131|
|Therapies|||||80,469||41,079||121,548|80,135|
|Lymphoedema|||||6,982||||6,982|42,394|
|Total|||||1,840,599||780,502||2,621,101|2,564,810|
##
##
##
##
|upport co|sts allocate|d to raising|funds|||||
|---|---|---|---|---|---|---|---|
|||||Premises||||
||Basisof
allocation|Information
technology|Administration
cosCs|costs
including
depreciation|Other
support
cosCs|Total
2022|Total 2021|
|Costs of||||||||
|generating
donations||9,125|51,783|55,661|37,478|154,047|109,413|
|and legacies||||||||
|Costs of||||||||
|trading||5,475|31,070|33,396|22,487|92,428|109,413|
|activities||||||||
|||14,600|82,853|89,057|59,965|246,475|218,826|
##
|xpenditure|on charita|ble activiti|es|||||
|---|---|---|---|---|---|---|---|
|||||Premises||||
||Basisof
allocation|Information
technology|Administration
costs|costs
including
depreciation|Other
support
cos'ts|Total
2022|Total 2021|
|In patient care
core services||40,758|231,297|248,617|167402|688.074|787,773|
|Family||2,433|13,809|14,843|9,994|41,079|21,883|
|Day
Therapy
Unit||608|3,452|3,712|2,498|10,270|21,883|
|Therapies||2,433|13,809|14,843|9,994|41,079|21,883|
|Lymphoedema|||||||21,8|
|||46,232|262,367|282,015|189,888|780,502|875,|
##
##
##
|||Unrestricted
General|funds:|Total 2022|Total2021|
|---|---|---|---|---|---|
||||||E|
|||E||||
||Audit fees|||||
|Audit|ofthe financial
statements|7,450||7,450|4,800|
|||7,450||7,450|4,800|
##
||2022|2021|
|---|---|---|
||E|E|
|Operating
leases - plant and machinery|19,743||
|Audit fees|7,450|4,800|
|Other non-audit
services|||
|Loss on disposal oftangible fixed assets|3,200||
|Depreciation
offixed assets|91,183|11L036|
##
##
##
##
##
|||2021|
|---|---|---|
|||8|
|Wages and
salaries|2,253,544|2,432,649|
|Social security
costs|204,396|197,480|
|Pension costs|203,567|180,370|
|Other staff costs|45,179|36,892|
|Total|2,706,686|2,847,391|
##
||2022|2021|
|---|---|---|
||0|0|
|Direct and charitable|62|55|
|Fund raising services|13|20|
|Governance costs|||
|Support services|15|14|
|Total||92|
##
##
##
|||Land and
buildings|Furniture
and
equipment|Motor vehicles|Total|
|---|---|---|---|---|---|
|At|1 April 2021|3,322,752|833,955|60,103|4,Z16,810|
|Additions|||8,558||8,558|
|At|3'I March 2022|3,322,752|842,513|60,103|4,225,368|
|At|1 April 2021|919,323|727,477|57,517|1,704,317|
|Charge for the year||63,849|26,687||91,183|
|At|31 March 2022|983,172|754,164|58,164|1,795,500|
|At|31 March 2022|2,339,580|88,349|1,939|2,429,868|
|At|31 March 2021|2,403,429|106,478|2,586|2,512,493|
##
##
|||2022|2021|
|---|---|---|---|
|||6|8|
|Other investments||879,541|868,943|
|||Listed investments|Total|
|||6|6|
|Cost or Valuation||||
|At 1 April 2021||868,943|868,943|
|Movement
in investment|funds|10,598|10,598|
|At 31 March 2022||879,541|879,541|
|Net book value||||
|At 31 March 2022||879,541|879,541|
|At 31 March 2021||868,943|&68,943|
##
##
##
##
|ors|||
|---|---|---|
||2022|2021|
||6|0|
|Trade debtors|389,018|387,054|
|Prepayments|47,314|21,603|
|VAT recoverable|22,507|7,458|
|Other debtors|1,0'I 8,011|10,847|
||1,476,850|426,962|
||||2022|2021|
|---|---|---|---|---|
||||6|0|
||Trade|creditors|80,945|10,465|
|Other|taxation|and sooal secunty|60,273|62,035|
||Other|creditors|20,322||
||Accruals||45,590|56,307|
||Deferred income||592,437|1,151,821|
||||799,567|1,280,628|
##
##
|||||2022|2021|
|---|---|---|---|---|---|
|||||6|6|
|Deferred|income at||1 April 2021|1,151,821|595,873|
|Resources||deferred|in the penod|404,632|958,353|
|Amounts|released from previous
periods|||(964,016)|(402,405)|
|Deferred||income|at year end|592,437|1,151,821|
##
##
##
||2022|2021|
|---|---|---|
||8|8|
|Land and buildings|||
|Within one year|15,000|27,000|
|Between one and five years|38,750|59,750|
||53,750|86,750|
##
##
##
|1March
-Funds|20|22||||
|---|---|---|---|---|---|
||Balance 1
April 2021
E|Irlcoming
resources
E|Resources
expended
E|Transfers
f.|Balance
31March 2022
f.|
|General||||||
|Unrestricted
funds|6,713,456|5,727,454|(3,193,924)|(3,700,000)|5,546,986|
|Designated||||||
|Organisational
support||||2,200,000|2,200,000|
|Income generation||||250,000|250,000|
|Service development||||600,000|600,000|
|Building and maintenance||||500,000|500,000|
|Information
technology||||150,000|150,000|
|||||3,700,000|3,700,000|
|Total Unrestricted
funds|6,713,456|5,727,454|(3,193,924)||9,246,986|
|Restricted||466,076|(226,041)||240,035|
|Total funds|6,713,456|6,193,530|(3,419,965)||9,487,021|
##
|||Balance 1
April 2020
f|Incoming resources|Resources
expended
f.||Balance
31March 2021
f|
|---|---|---|---|---|---|---|
|General|||||||
|unrestricted|funds|6,639,622|3,008,472|(2,934,638)||6,713,456|
|Restricted|||690,996|(690,996l|||
||||||year's||
|Total funds||6,639,622|3,699,468|(3,625,634)||6,713,456|
##
||Unrestricted
General
8|Unrestricted
Designated
8|Restricted
funds
8|Total funds 2022
g|
|---|---|---|---|---|
|Tangible fixed assets|2,429,868|||2,429,868|
|Fixed asset investments|879,541|||879,541|
|Current assets|3,037,144|3,700,000|240,035|6,977, 179|
|Current liabilities|(799,567)|||(799,567)|
|Totalnet assets|5,546,986|3,700,000|240,035|9,487,021|
||Unrestricted
General
6|Total funds
8|
|---|---|---|
|Tangible fixed assets|2,512,493|2,512,493|
|Fixed asset investments|868,943|868,943|
|Current assets|4,612,648|4,612,648|
|Current liabilities|(1,280,628)|(1,280,628)|
|Total net assets|6,713,456|6,713,456|
##
##
|||||||At|1April 2021|Cash flow|At 31 March 2022|
|---|---|---|---|---|---|---|---|---|---|
||||||||E|E.|E|
|Cash|at|bank|and|in|hand||4,185,337|1,314,992|5,500,329|
|||Net|debt||||4,185,337|1,314,992|5,500,329|
|||||||At|1April 2020|Cash flow|At 31 March 2021|
||||||||f.|E|E|
|Cash|at|bank|and|in|hand||3,487,346|697,991|4,185,337|
|||Net|debt||||3,487,346|697,991|4,185,337|
||Total restricted funds 2022|Restricted funds 2021|
|---|---|---|
||E|E|
|Donations and legacies|466,076|690,996|
|Total income|466,076|690,996|
|Charitable
activities|(226,041)|(690,996)|
|Total expenditure|(226,041)|(690,996)|
|Net mcome|240,035||
|1otal funds carried forward|240,035||